Last $22.38 USD
Change Today -0.37 / -1.63%
Volume 268.3K
HWAY On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

healthways inc (HWAY) Snapshot

Open
$22.76
Previous Close
$22.75
Day High
$23.30
Day Low
$22.37
52 Week High
02/27/15 - $23.30
52 Week Low
10/24/14 - $13.99
Market Cap
792.0M
Average Volume 10 Days
376.3K
EPS TTM
$0.16
Shares Outstanding
35.4M
EX-Date
--
P/E TM
142.3x
Dividend
--
Dividend Yield
--
Current Stock Chart for HEALTHWAYS INC (HWAY)

healthways inc (HWAY) Related Bloomberg News

View More Bloomberg News

healthways inc (HWAY) Related Businessweek News

View More BusinessWeek News

healthways inc (HWAY) Details

Healthways, Inc., through its subsidiaries, provides specialized solutions to help people to enhance their physical, emotional, and social well-being. The company offers specific and personalized interventions for each individual in a population, irrespective of health status, age, or payor; and delivers a range of methods desired by an individual, including venue-based face-to-face interactions; print; phone; mobile and remote devices; and on-line services, as well as other combination to motivate and sustain healthy behaviors. It also provides wellness and disease prevention solutions through total population screening, well-being assessments, and supportive interventions; and well-being improvement programs and networks, such as fitness, weight management, stress management, financial and lifestyle management skills, chiropractic, and complementary and alternative medicine. In addition, the company promotes personal change and improvement in the lifestyle behaviors; and offers educational materials and personal interactions with trained healthcare professionals to create and sustain healthier behaviors for individuals who are in the early stages of chronic conditions. Further, it provides evidence-based clinical guidelines to optimize patient health outcomes; develops care support plans; offers local market resources to address acute episodic interventions; coordinates members’ care; provides software technology solutions and management consulting in support of well-being improvement services; and offers high-risk care management for members at risk for hospitalization due to complex conditions. The company has operations in Brazil, Australia, and France. It offers its products and services to health plans, employers, integrated healthcare systems, hospitals, physicians, and government entities. The company was founded in 1981 and is headquartered in Franklin, Tennessee.

healthways inc (HWAY) Top Compensated Officers

Chief Executive Officer, President and Execut...
Total Annual Compensation: $712.4K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $378.3K
President of Healthways International
Total Annual Compensation: $434.9K
Chief Commercial Officer and Executive Vice P...
Total Annual Compensation: $700.0K
Senior Vice President and General Counsel
Total Annual Compensation: $256.5K
Compensation as of Fiscal Year 2013.

healthways inc (HWAY) Key Developments

Healthways Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Earnings Guidance for 2015

Healthways Inc. announced unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported revenues of $199,136,000 against $169,235,000 a year ago. Operating income was $6,659,000 against operating loss of $2,998,000 a year ago. Income before income taxes was $2,551,000 against loss before income taxes of $7,591,000 a year ago. Net income was $2,578,000 against net loss of $5,290,000 a year ago. Diluted earnings per share were $0.07 against LPS of $0.15 a year ago. Adjusted net income was $9,058,000 against adjusted net loss of $4,144,000 a year ago. Adjusted net income per share was $0.25 against adjusted LPS of $0.12 a year ago. Cash flow from operations was approximately $20 million, and capital expenditures totaled approximately $11 million, primarily due to the timing of accounts receivable collections, which resulted in DSO at December 31, 2014 increasing by almost 10 days to 59 days compared with previous year-end. This increase is related to routine timing and not indicative of underlying collectibility issues. For the year, the company reported revenues of $742,183,000 against $663,285,000 a year ago. Operating income was $7,433,000 against $1,902,000 a year ago. Loss before income taxes was $10,148,000 against $14,177,000 a year ago. Net loss was $5,561,000 against $8,541,000 a year ago. Diluted loss per share was $0.16 against $0.25 a year ago. Adjusted net income was $9,989,000 against adjusted net loss of $6,648,000 a year ago. Adjusted net income per share was $0.27 against adjusted LPS of $0.19 a year ago. Net cash flows provided by operating activities were $52,098,000 against $71,528,000 a year ago. Acquisition of property and equipment was $42,991,000 against $41,346,000 a year ago. Adjusted EBITDA was $78,526,000 against $54,693,000 a year ago. Adjusted net cash flows provided by operating activities were $56.1 million. For 2015, the company expects revenues to be in the range of $800 million to $825 million, EBITDA margin to be in the range of 10.5% to 11.0%. The company expects adjusted operating cash flow for 2015 in a range of $80 million to $90 million, which excludes cash payments for legal settlements of $13.9 million, total capital expenditures of $37 million to $42 million, and further improvement in its ratio of total debt to EBITDA, as calculated under its credit agreement, by the end of 2015. Net cash flows provided by operating activities to be in the range of $66.1 million to $76.1 million, adjusted EPS to be in the range of $0.35 to $0.47, EPS on GAAP basis to be in the range of $0.23 to $0.35 and LPS attributable to non-cash interest charges of $0.12. The company currently expects that most of 2015 free cash flow will be applied towards debt reduction.

Healthways Mulls Options

Healthways Inc. (NasdaqGS:HWAY) is evaluating alternatives. The company announced that its Board of Directors is exploring strategic alternatives to enhance shareholder value. The Board has retained J.P. Morgan Securities LLC as its financial advisor to assist in its evaluation of strategic alternatives.

Healthways Inc. to Report Q4, 2014 Results on Feb 24, 2015

Healthways Inc. announced that they will report Q4, 2014 results at 5:00 PM, Eastern Standard Time on Feb 24, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HWAY:US $22.38 USD -0.37

HWAY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BioScrip Inc $6.11 USD +0.19
Civitas Solutions Inc $18.99 USD -0.13
Five Star Quality Care Inc $3.64 USD -0.07
National HealthCare Corp $63.01 USD -1.04
Providence Service Corp/The $46.00 USD -0.01
View Industry Companies
 

Industry Analysis

HWAY

Industry Average

Valuation HWAY Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.1x
Price/Book 2.6x
Price/Cash Flow 16.6x
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HEALTHWAYS INC, please visit www.healthways.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.